Efficacy of Colchicine Treatment for Adults Hospitalized with COVID-19
RECOVERY, a large, randomized clinical trial, assessed the efficacy of colchicine, a proposed treatment for inflammation associated with COVID-19.
RECOVERY, a large, randomized clinical trial, assessed the efficacy of colchicine, a proposed treatment for inflammation associated with COVID-19.
Researchers conducted subgroup analysis of revenfenacin phase 3 trial data to assess health status improvements in women vs men with moderate to severe COPD.
Patients who have severe eosinophilic asthma that is uncontrolled on omalizumab may be effectively switched to mepolizumab.
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Grandmaternal smoking during pregnancy is associated with a higher asthma risk and lower lung function in male grandchildren.
The Epic Deterioration Index (EDI) can identify subsets of high- and low-risk patients with coronavirus disease 2019 (COVID-19).
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.
There appears to be a low risk of invasive fungal secondary infection, especially aspergillosis, in patients with SARS-CoV-2-related pneumonia and no underlying immunosuppression.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate may reduce the risk of death compared with glycopyrrolate/formoterol fumarate in patients with COPD.
The effects of positive end expiratory pressure in COVID-19-related acute respiratory distress syndrome (ARDS) are similar to those reported in classical ARDS.